- Type / Class
- Equity / COM
- Shares outstanding
- 258,506,508
- Total 13F shares
- 77,232,361
- Share change
- +2,934,824
- Total reported value
- $75,678,982
- Put/Call ratio
- 17%
- Price per share
- $0.98
- Number of holders
- 120
- Value change
- -$1,733,880
- Number of buys
- 57
- Number of sells
- 52
Quarterly Holders Quick Answers
What is CUSIP 29664W105?
CUSIP 29664W105 identifies ESPR - Esperion Therapeutics, Inc. - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 29664W105:
Top shareholders of ESPR - Esperion Therapeutics, Inc. - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| WASATCH ADVISORS LP |
13F
|
Company |
5.1%
|
13,139,556
|
$18,263,983 | — | 30 Jun 2023 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
3.6%
|
9,193,000
|
$12,778,270 | — | 30 Jun 2023 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
1.9%
|
4,975,000
|
$6,915,250 | — | 30 Jun 2023 | |
| Meditor Group Ltd |
13F
|
Company |
1.7%
|
4,402,973
|
$6,120,132 | — | 30 Jun 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.6%
|
4,263,265
|
$5,925,938 | — | 30 Jun 2023 | |
| Bellevue Group AG |
13F
|
Company |
1.6%
|
4,208,264
|
$5,849,487 | — | 30 Jun 2023 | |
| BIOTECH TARGET N V |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
4,477,964
|
$5,575,065 | — | 24 May 2021 | |
| PLATINUM INVESTMENT MANAGEMENT LTD |
13F
|
Company |
1.3%
|
3,469,634
|
$4,822,791 | — | 30 Jun 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.3%
|
3,346,726
|
$4,651,949 | — | 30 Jun 2023 | |
| Two Seas Capital LP |
13F
|
Company |
1.1%
|
2,941,872
|
$4,089,202 | — | 30 Jun 2023 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.82%
|
2,132,309
|
$2,963,910 | — | 30 Jun 2023 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.72%
|
1,850,000
|
$2,571,500 | — | 30 Jun 2023 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.66%
|
1,705,605
|
$2,370,791 | — | 30 Jun 2023 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.51%
|
1,316,100
|
$1,829,379 | — | 30 Jun 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.51%
|
1,307,452
|
$1,817,359 | — | 30 Jun 2023 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.46%
|
1,176,848
|
$1,635,819 | — | 30 Jun 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.37%
|
965,421
|
$1,341,936 | — | 30 Jun 2023 | |
| BRAIDWELL LP |
13F
|
Company |
0.35%
|
895,949
|
$1,245,369 | — | 30 Jun 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.32%
|
825,711
|
$1,147,738 | — | 30 Jun 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.32%
|
823,507
|
$1,144,674 | — | 30 Jun 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.27%
|
706,775
|
$982,417 | — | 30 Jun 2023 | |
| Monaco Asset Management SAM |
13F
|
Company |
0.27%
|
695,302
|
$966,470 | — | 30 Jun 2023 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.26%
|
685,032
|
$952,194 | — | 30 Jun 2023 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.25%
|
643,072
|
$893,870 | — | 30 Jun 2023 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.19%
|
500,769
|
$696,000 | — | 30 Jun 2023 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.17%
|
430,922
|
$599,000 | — | 30 Jun 2023 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.17%
|
427,792
|
$594,631 | — | 30 Jun 2023 | |
| XTX Topco Ltd |
13F
|
Company |
0.16%
|
416,752
|
$579,285 | — | 30 Jun 2023 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.13%
|
334,267
|
$464,631 | — | 30 Jun 2023 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.12%
|
321,806
|
$447,310 | — | 30 Jun 2023 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.12%
|
315,929
|
$439,141 | — | 30 Jun 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.12%
|
302,449
|
$420,404 | — | 30 Jun 2023 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.11%
|
296,947
|
$412,756 | — | 30 Jun 2023 | |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.1%
|
254,265
|
$353,428 | — | 30 Jun 2023 | |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO |
13F
|
Company |
0.1%
|
252,516
|
$351,000 | — | 30 Jun 2023 | |
| PINNACLE ASSOCIATES LTD |
13F
|
Company |
0.1%
|
249,838
|
$347,275 | — | 30 Jun 2023 | |
| FMR LLC |
13F
|
Company |
0.09%
|
240,481
|
$334,269 | — | 30 Jun 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.09%
|
223,747
|
$311,009 | — | 30 Jun 2023 | |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP |
13F
|
Company |
0.09%
|
222,482
|
$309,250 | — | 30 Jun 2023 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.08%
|
204,072
|
$283,660 | — | 30 Jun 2023 | |
| SILVERBACK ASSET MANAGEMENT LLC |
13F
|
Company |
0.04%
|
100,000
|
$280,371 | — | 30 Jun 2023 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.08%
|
196,663
|
$273,362 | — | 30 Jun 2023 | |
| NJ State Employees Deferred Compensation Plan |
13F
|
Company |
0.08%
|
195,125
|
$271,224 | — | 30 Jun 2023 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.07%
|
187,937
|
$261,232 | — | 30 Jun 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.07%
|
184,121
|
$255,928 | — | 30 Jun 2023 | |
| Pentwater Capital Management LP |
13F
|
Company |
0.07%
|
181,290
|
$251,993 | — | 30 Jun 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.06%
|
161,230
|
$224,109 | — | 30 Jun 2023 | |
| Verition Fund Management LLC |
13F
|
Company |
0.06%
|
150,695
|
$209,466 | — | 30 Jun 2023 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.04%
|
111,482
|
$177,256 | — | 30 Jun 2023 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.05%
|
123,981
|
$172,334 | — | 30 Jun 2023 |
Institutional Holders of Esperion Therapeutics, Inc. - COM (ESPR) as of Q3 2023
As of 30 Sep 2023,
Esperion Therapeutics, Inc. - COM (ESPR) was held by
120 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
77,232,361 shares.
The largest 10 holders included
WASATCH ADVISORS LP, Two Seas Capital LP, MILLENNIUM MANAGEMENT LLC, VANGUARD GROUP INC, Bellevue Group AG, Meditor Group Ltd, PLATINUM INVESTMENT MANAGEMENT LTD, Point72 Asset Management, L.P., JACOBS LEVY EQUITY MANAGEMENT, INC, and MORGAN STANLEY.
This page lists
120
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2023 vs Q2 2023 Across Filers
Q2 2023 holders
121
Q3 2023 holders
120
Holder diff
-1
| Investor | Q2 2023 Shares | Q3 2023 Shares | Share Diff | Share Chg % | Q2 2023 Value $ | Q3 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.